Abstract:Background. Berberine, an isoquinoline alkaloid derived from plants, has been used as a traditional medicine for several diseases, including bacterial diarrhea. Recently, Berberine has been shown to suppress tumor cell growth and regulate several signaling pathways involved in apoptosis and cell cycle arrest In Vitro. However information is limited regarding mechanisms of Berberine's action in diseases. This study was designed to investigate Berberine's anti-tumor and anti-inflammatory effects. Methods. 7 patients with familial adenomatous polyposis history and recurrent colon adenomatous polyps were enrolled for oral Berberine treatment (0.1 g, 3 times/day) immediately following polypectomy and patients followed-up up to two years. Animal studies were performed on C57BL/6 mice administered 3% DSS in drinking water, or water only, for 7 days. Mice were given Berberine (200 μg/ g body weight, once daily) via gavage from day 4-7. Colon sections were prepared for H&E staining to determine intestinal tissue injury score (0: normal, 18: severe colitis). Mouse colon epithelial cells derived from wt Immorto (YAMC), Immorto-Min mice carrying APC min mutation (IMCE), and IMCE cells over-expression of Ras (IRas) were treated with Berberine (25 μM 200 μM) in the presence or absence of TNF (100 ng/ml), EGF (10 ng/ ml) or caspase inhibitor for detecting apoptosis using Annexin staining and TUNEL assay, signaling by Western blot analysis, and colony formation in agar. Results. 6 (7 total) patients showed no recurrence of polyps during the 2-year Berberine treatment. Berberine induced apoptosis in IMCE and IRas, but not YAMC cells and inhibited IRas cell colony formation in a concentration-dependent manner. Berberine stimulated p53 activation and blocked TNF-induced NFκB activation. In addition, Berberine inhibited EGF-stimulated EGF receptor activation and cell proliferation. However, Berbeine did not activate caspase 3 or 9 nor did the caspase inhibitor prevent Berberine-induced apoptosis. DSS-induced colitis (score: 15±0.9) was significantly reduced by Berberine treatment (score: 10±1.3, p<0.05). Conclusion. Berberine exerts the anti-tumor effect, which may be through induction of tumor cell apoptosis and inhibition of the action of tumor-promoting factors, including EGF and TNF. In addition, anti-inflammatory effects of Berberine may contribute to prevention of colitisassociated tumor development. The role of p53 activation and NFκB inhibition by Berberine in prevention of tumor development and inflammation is under investigation. Thus, Berberine may serve as a potential alternative approach for treating intestinal inflammatory diseases and tumor development.

Berberis vulgaris L. Root Extract as a Multi-Target Chemopreventive Agent against Colon Cancer Causing Apoptosis in Human Colon Adenocarcinoma Cell Lines

Antioxidant and Cytotoxic Properties of Berberis vulgaris (L.) Stem Bark Dry Extract

Berberine: Potential preventive and therapeutic strategies for human colorectal cancer

Berberine: An inspiring resource for the treatment of colorectal diseases

Berberine as a Potential Agent for the Treatment of Colorectal Cancer

Computational and Experimental Prediction of Molecules Involved in the Anti-Melanoma Action of Berberine

Comparative Pharmacoproteomics Reveals Potential Targets for Berberine, a Promising Therapy for Colorectal Cancer.

Pharmacological Potential of Three Berberine-Containing Plant Extracts Obtained from Berberis vulgaris L., Mahonia aquifolium (Pursh) Nutt., and Phellodendron amurense Rupr

Ameliorating Intestinal Inflammation and Preventing Colon Tumor Development by the Plant Extract, Berberine

Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo

The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells

Cnsc-02. Anticancer Ability Of The Berberine To Promote The Apoptosis Effect And Attenuate The Ros Generation Capacity On Dbtrg Brain Cancer Cells

Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells

Multiple Effects of Berberine Derivatives on Colon Cancer Cells

Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota

Berberine Targets Ap-2/Htert, Nf-Kappa B/Cox-2, Hif-1 Alpha/Vegf And Cytochrome-C/Caspase Signaling To Suppress Human Cancer Cell Growth

Berberine Inhibits Proliferation and Induces G0/G1 Phase Arrest in Colorectal Cancer Cells by Downregulating IGF2BP3.

The Anti-Cancer Mechanisms of Berberine: A Review

Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer

Berberine Exerts Its Antineoplastic Effects by Reversing the Warburg Effect Via Downregulation of the Akt/mTOR/GLUT1 Signaling Pathway

Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula